GlobalData on MSN23d
EC approves Roche’s monoclonal antibody PiaSky to treat PNH
The European Commission (EC) has approved Roche’s recycling monoclonal antibody, PiaSky (crovalimab), for the treatment of ...
GlobalData on MSN6d
FDA approves Roche’s Tecentriq Hybreza for cancer
The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer ...
Nasdaq23d
European Commission Approves Roche's PiaSky For Paroxysmal Nocturnal Hemoglobinuria
(RTTNews) - Roche (RHHBY) announced that the European Commission has approved PiaSky (crovalimab), a novel recycling monoclonal antibody that inhibits the complement protein C5. It is approved for ...
pharmaphorum15d
Novartis' oral PNH drug Fabhalta rolls out in England, Wales
Fabhalta (iptacopan) was approved by UK drugs regulator the MHRA last month, becoming an option for an estimated 220 out of ...
Yahoo Finance10d
Cox Co., Ltd. (9876.T)
showing an improvement in delaying time to onset of confirmed disability progression. LLY launches a discounted version of Zepbound. European Commission approves JNJ's Balversa, MRK's Winrevair and ...